name:-0.56624388694763
name:-0.10877895355225
name:-0.035580158233643
Achillion Pharmaceuticals, Inc. Patent Filings

Achillion Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Achillion Pharmaceuticals, Inc..The latest application filed is for "quinazoline and indole compounds to treat medical disorders".

Company Profile
54.142.177
  • Achillion Pharmaceuticals, Inc. - Boston MA
  • Achillion Pharmaceuticals, Inc. - Blue Bell PA US
  • Achillion Pharmaceuticals, Inc. - New Haven CT US
  • ACHILLION PHARMACEUTICALS, INC. - Haven CT US
  • Achillion Pharmaceuticals, Inc - New Haven CT US
  • ACHILLION PHARMACEUTICALS, INC. - 300 George Street New Haven CT
  • Achillion Pharmaceuticals, Inc. -
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Pharmaceutical compounds for treatment of medical disorders
Grant 11,447,465 - Wiles , et al. September 20, 2
2022-09-20
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
Grant 11,407,738 - Wiles , et al. August 9, 2
2022-08-09
Quinazoline And Indole Compounds To Treat Medical Disorders
App 20220119400 - WILES; Jason Allan ;   et al.
2022-04-21
Targeted Dosing For The Treatment Of Complement Mediated Disorders
App 20220079943 - Huang; Mingjun ;   et al.
2022-03-17
Quinazoline and indole compounds to treat medical disorders
Grant 11,248,000 - Wiles , et al. February 15, 2
2022-02-15
Morphic Forms Of Complement Factor D Inhibitors
App 20210332026 - Phadke; Avinash ;   et al.
2021-10-28
Macrocyclic Compounds For Treatment Of Medical Disorders
App 20210300934 - WILES; Jason Allan ;   et al.
2021-09-30
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Medical Disorders
App 20210269458 - WILES; Jason Allan ;   et al.
2021-09-02
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
Grant 11,084,800 - Wiles , et al. August 10, 2
2021-08-10
Complement Alternative Pathway-associated Nephropathy Biomarkers
App 20210215714 - HUANG; Mingjun ;   et al.
2021-07-15
Macrocyclic compounds for treatment of medical disorders
Grant 11,053,253 - Wiles , et al. July 6, 2
2021-07-06
Disubstituted compounds for treatment of medical disorders
Grant 11,001,600 - Wiles , et al. May 11, 2
2021-05-11
Amino Compounds For Treatment Of Immune And Inflammatory Disorders
App 20210122733 - WILES; Jason Allan ;   et al.
2021-04-29
Amide Compounds For Treatment Of Immune And Inflammatory Disorders
App 20210115034 - Wiles; Jason Allan ;   et al.
2021-04-22
Quinazoline and indole compounds to treat medical disorders
Grant 10,961,252 - Wiles , et al. March 30, 2
2021-03-30
Amide compounds for treatment of immune and inflammatory disorders
Grant 10,919,884 - Wiles , et al. February 16, 2
2021-02-16
Amino compounds for treatment of immune and inflammatory disorders
Grant 10,906,887 - Wiles , et al. February 2, 2
2021-02-02
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
Grant 10,822,352 - Wiles , et al. November 3, 2
2020-11-03
Compounds for treatment of immune inflammatory disorders
Grant 10,807,952 - Wiles , et al. October 20, 2
2020-10-20
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Immune And Inflammatory Disorders
App 20200262818 - Wiles; Jason Allan ;   et al.
2020-08-20
Amino compounds for treatment of complement mediated disorders
Grant 10,689,409 - Gadhachanda , et al.
2020-06-23
Quinazoline and Indole Compounds to Treat Medical Disorders
App 20200165262 - Wiles; Jason Allan ;   et al.
2020-05-28
Amino compounds for treatment of medical disorders
Grant 10,660,876 - Wiles , et al.
2020-05-26
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
Grant 10,662,175 - Wiles , et al.
2020-05-26
Therapeutic Regimens For Treatment Of Paroxysmal Nocturnal Hemoglobinuria
App 20200101071 - Huang; Mingjun ;   et al.
2020-04-02
Aryi, Heteroaryl, and Heterocyclic Pharmaceutical Compounds for Treatment of Medical Disorders
App 20200071301 - Wiles; Jason Allan ;   et al.
2020-03-05
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20200062790 - Wiles; Jason Allan ;   et al.
2020-02-27
Ether compounds for treatment of complement mediated disorders
Grant 10,550,140 - Wiles , et al. Fe
2020-02-04
Macrocyclic Compounds For Treatment Of Medical Disorders
App 20200002347 - Wiles; Jason Allan ;   et al.
2020-01-02
Pharmaceutical Compounds For Treatment Of Medical Disorders
App 20190382376 - Wiles; Jason Allan ;   et al.
2019-12-19
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Grant 10,464,956 - Wiles , et al. No
2019-11-05
Amide compounds for treatment of complement mediated disorders
Grant 10,428,094 - Wiles , et al. October 1, 2
2019-10-01
Compounds for treatment of complement mediated disorders
Grant 10,428,095 - Wiles , et al. October 1, 2
2019-10-01
Ether compounds for treatment of medical disorders
Grant 10,385,097 - Wiles , et al. A
2019-08-20
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
Grant 10,370,394 - Wiles , et al.
2019-08-06
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Medical Disorders
App 20190211033 - Wiles; Jason Allan ;   et al.
2019-07-11
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20190185498 - Wiles; Jason Allan ;   et al.
2019-06-20
Phosphonate compounds for treatment of complement mediated disorders
Grant 10,301,336 - Wiles , et al.
2019-05-28
Amino Compounds For Treatment Of Complement Mediated Disorders
App 20190144473 - Gadhachanda; Venkat Rao ;   et al.
2019-05-16
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
Grant 10,287,301 - Wiles , et al.
2019-05-14
Quinazoline and Indole Compounds to Treat Medical Disorders
App 20190135825 - Wiles; Jason Allan ;   et al.
2019-05-09
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Grant 10,253,053 - Wiles , et al.
2019-04-09
Phosphonate Compounds For Treatment Of Complement Mediated Disorders
App 20190085005 - Wiles; Jason Allan ;   et al.
2019-03-21
Ether Compounds For Treatment Of Complement Mediated Disorders
App 20190048033 - Wiles; Jason Allan ;   et al.
2019-02-14
Therapeutic Regimens For Treatment Of Paroxysmal Nocturnal Hemoglobinuria
App 20190038623 - Huang; Mingjun ;   et al.
2019-02-07
Compounds For Treatment Of Complement Mediated Disorders
App 20190031692 - Wiles; Jason Allan ;   et al.
2019-01-31
Amino compounds for treatment of complement mediated disorders
Grant 10,189,869 - Gadhachanda , et al. Ja
2019-01-29
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20190023729 - Wiles; Jason Allan ;   et al.
2019-01-24
Amide compounds for treatment of medical disorders
Grant 10,138,225 - Wiles , et al. Nov
2018-11-27
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Medical Disorders
App 20180305375 - Wiles; Jason Allan ;   et al.
2018-10-25
Subsituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20180303800 - Wiles; Jason Allan ;   et al.
2018-10-25
Ether compounds for treatment of complement mediated disorders
Grant 10,106,563 - Wiles , et al. October 23, 2
2018-10-23
Alkyne Compounds for Treatment of Complement Mediated Disorders
App 20180298043 - Wiles; Jason Allan ;   et al.
2018-10-18
Phosphonate compounds for treatment of complement mediated disorders
Grant 10,100,072 - Wiles , et al. October 16, 2
2018-10-16
Alkyne Compounds For Treatment Of Complement Mediated Disorders
App 20180291047 - Wiles; Jason Allan ;   et al.
2018-10-11
Alkyne Compounds For Treatment Of Complement Mediated Disorders
App 20180291046 - Wiles; Jason Allan ;   et al.
2018-10-11
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections
Grant 10,092,547 - Wiles , et al. October 9, 2
2018-10-09
Compounds for the treatment of medical disorders
Grant 10,092,584 - Wiles , et al. October 9, 2
2018-10-09
Compounds for treatment of complement mediated disorders
Grant 10,087,203 - Wiles , et al. October 2, 2
2018-10-02
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Grant 10,081,645 - Wiles , et al. September 25, 2
2018-09-25
Compounds For Treatment Of Immune Inflammatory Disorders
App 20180201580 - Wiles; Jason Allan ;   et al.
2018-07-19
Amide Compounds For Treatment Of Immune And Inflammatory Disorders
App 20180186782 - Wiles; Jason Allan ;   et al.
2018-07-05
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
Grant 10,011,612 - Wiles , et al. July 3, 2
2018-07-03
Amino Compounds For Treatment Of Immune And Inflammatory Disorders
App 20180179185 - Wiles; Jason Allan ;   et al.
2018-06-28
Amino Compounds For Treatment Of Medical Disorders
App 20180177761 - Wiles; Jason Allan ;   et al.
2018-06-28
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Immune And Inflammatory Disorders
App 20180179186 - Wiles; Jason Allan ;   et al.
2018-06-28
Amide compounds for treatment of complement mediated disorders
Grant 10,005,802 - Wiles , et al. June 26, 2
2018-06-26
Phosphonate compounds for treatment of medical disorders
Grant 10,000,516 - Wiles , et al. June 19, 2
2018-06-19
Alkyne Compounds For Treatment Of Complement Mediated Disorders
App 20180072762 - Wiles; Jason Allan ;   et al.
2018-03-15
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20180055824 - Wiles; Jason Allan ;   et al.
2018-03-01
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20180030075 - Wiles; Jason Allan ;   et al.
2018-02-01
Combination Therapy Regimen For Treatment Of Selected HCV Genotypes
App 20180021360 - Beumont; Maria Gloria ;   et al.
2018-01-25
Combination Drug Treatment For Hepatitis C Infection
App 20180021361 - Beumont; Maria Gloria ;   et al.
2018-01-25
Compounds for Treatment of Complement Mediated Disorders
App 20180022767 - Wiles; Jason Allan ;   et al.
2018-01-25
Ether Compounds For Treatment Of Complement Mediated Disorders
App 20180022766 - Wiles; Jason Allan ;   et al.
2018-01-25
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,833,440 - Wiles , et al. December 5, 2
2017-12-05
Alkyne compounds for treatment of complement mediated disorders
Grant 9,828,396 - Wiles , et al. November 28, 2
2017-11-28
Combination Drug Treatment For Hepatitis C Infection
App 20170319572 - Beumont; Maria Gloria ;   et al.
2017-11-09
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
Grant 9,796,741 - Gadhachanda , et al. October 24, 2
2017-10-24
Carbamate, Ester, And Ketone Compounds For Treatment Of Complement Mediated Disorders
App 20170298085 - Wiles; Jason Allan ;   et al.
2017-10-19
Amide Compounds For Treatment Of Complement Mediated Disorders
App 20170298084 - Wiles; Jason Allan ;   et al.
2017-10-19
Phosphonate Compounds For Treatment Of Complement Mediated Disorders
App 20170260219 - Wiles; Jason Allan ;   et al.
2017-09-14
Compounds for treatment of complement mediated disorders
Grant 9,758,537 - Wiles , et al. September 12, 2
2017-09-12
Ether compounds for treatment of complement mediated disorders
Grant 9,732,104 - Gadhachanda , et al. August 15, 2
2017-08-15
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
Grant 9,732,103 - Wiles , et al. August 15, 2
2017-08-15
Factor D Inhibitors Useful for Treating Inflammatory Disorders
App 20170226142 - Wiles; Jason Allan ;   et al.
2017-08-10
Amino Compounds for Treatment of Complement Mediated Disorders
App 20170189410 - Gadhachanda; Venkat Rao ;   et al.
2017-07-06
Amide compounds for treatment of complement mediated disorders
Grant 9,695,205 - Wiles , et al. July 4, 2
2017-07-04
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20170157096 - Wiles; Jason Allan ;   et al.
2017-06-08
Phosphonate compounds for treatment of complement mediated disorders
Grant 9,663,543 - Wiles , et al. May 30, 2
2017-05-30
Factor D inhibitors useful for treating inflammatory disorders
Grant 9,643,986 - Wiles , et al. May 9, 2
2017-05-09
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
Grant 9,610,317 - Phadke , et al. April 4, 2
2017-04-04
Combination Therapy Regimen For Treatment Of Hcv
App 20170087174 - Beumont; Maria Gloria ;   et al.
2017-03-30
Amino compounds for treatment of complement mediated disorders
Grant 9,598,446 - Gadhachanda , et al. March 21, 2
2017-03-21
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,592,222 - Wiles , et al. March 14, 2
2017-03-14
Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Medical Disorders
App 20170066783 - Wiles; Jason Allan ;   et al.
2017-03-09
Phosphonate Compounds for Treatment of Medical Disorders
App 20170057983 - Wiles; Jason Allan ;   et al.
2017-03-02
Compounds for the Treatment of Medical Disorders
App 20170056428 - Wiles; Jason Allan ;   et al.
2017-03-02
Amide Compounds for Treatment of Medical Disorders
App 20170057950 - Wiles; Jason Allan ;   et al.
2017-03-02
Ether Compounds for Treatment of Medical Disorders
App 20170057993 - Wiles; Jason Allan ;   et al.
2017-03-02
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20170007579 - Wiles; Jason Allan ;   et al.
2017-01-12
Sovaprevir polymorphs and methods of manufacture thereof
Grant 9,540,346 - Phadke January 10, 2
2017-01-10
Aryl, Heteroaryl, And Heterocyclic Compounds For Treatment Of Complement Mediated Disorders
App 20160362399 - Wiles; Jason Allan ;   et al.
2016-12-15
Phosphonate Compounds For Treatment Of Complement Mediated Disorders
App 20160362432 - Wiles; Jason Allan ;   et al.
2016-12-15
Compounds For Treatment Of Complement Mediated Disorders
App 20160361329 - Wiles; Jason Allan ;   et al.
2016-12-15
Ether Compounds For Treatment Of Complement Mediated Disorders
App 20160362433 - Wiles; Jason Allan ;   et al.
2016-12-15
Amide Compounds For Treatment Of Complement Mediated Disorders
App 20160362398 - Wiles; Jason Allan ;   et al.
2016-12-15
Process for producing Sovaprevir
Grant 9,481,708 - Phadke , et al. November 1, 2
2016-11-01
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,474,742 - Wiles , et al. October 25, 2
2016-10-25
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,468,629 - Wiles , et al. October 18, 2
2016-10-18
Highly active nucleoside derivative for the treatment of HCV
Grant 9,447,132 - Deshpande , et al. September 20, 2
2016-09-20
Sovaprevir Polymorphs And Methods Of Manufacture Thereof
App 20160176847 - Phadke; Avinash
2016-06-23
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20160113907 - Wiles; Jason Allan ;   et al.
2016-04-28
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20160115157 - Wiles; Jason Allan ;   et al.
2016-04-28
4-amino-4-oxobutanoyl Peptides As Inhibitors Of Viral Replication
App 20160082069 - Phadke; Avinash ;   et al.
2016-03-24
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 9,273,082 - Wiles , et al. March 1, 2
2016-03-01
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
Grant 9,233,136 - Phadke , et al. January 12, 2
2016-01-12
Sovaprevir polymorphs and methods of manufacture thereof
Grant 9,227,952 - Phadke January 5, 2
2016-01-05
Novel Process For Producing Sovaprevir
App 20150322109 - Phadke; Avinash ;   et al.
2015-11-12
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
Grant 9,133,115 - Phadke , et al. September 15, 2
2015-09-15
Biphenyl imidazoles and related compounds useful for treating HCV infections
Grant 9,125,904 - Wiles , et al. September 8, 2
2015-09-08
Compounds for Treatment of Complement Mediated Disorders
App 20150239838 - Phadke; Avinash S. ;   et al.
2015-08-27
Amide Compounds for Treatment of Complement Mediated Disorders
App 20150239893 - Wang; Qiuping ;   et al.
2015-08-27
Carbamate, Ester, and Ketone Compounds for Treatment of Complement Mediated Disorders
App 20150239919 - Gadhachanda; Venkat Rao ;   et al.
2015-08-27
Amino Compounds for Treatment of Complement Mediated Disorders
App 20150239894 - Gadhachanda; Venkat Rao ;   et al.
2015-08-27
Ether Compounds for Treatment of Complement Mediated Disorders
App 20150239920 - Gadhachanda; Venkat Rao ;   et al.
2015-08-27
Factor D Inhibitors Useful for Treating Inflammatory Disorders
App 20150239837 - Wiles; Jason Allan ;   et al.
2015-08-27
Phosphonate Compounds for Treatment of Complement Mediated Disorders
App 20150239921 - Wiles; Jason Allan ;   et al.
2015-08-27
Alkyne Compounds for Treatment of Complement Mediated Disorders
App 20150239868 - Pais; Godwin ;   et al.
2015-08-27
Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Complement Mediated Disorders
App 20150239895 - Gadhachanda; Venkat Rao ;   et al.
2015-08-27
Processes for Producing sovaprevir
Grant 9,115,175 - Phadke , et al. August 25, 2
2015-08-25
ACH-0142684 sodium salt polymorph, composition including the same, and method of manufacture thereof
Grant 9,085,607 - Phadke , et al. July 21, 2
2015-07-21
Process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
Grant 9,006,423 - Phadke , et al. April 14, 2
2015-04-14
8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as anti-infective agents
Grant 8,946,422 - Bradbury , et al. February 3, 2
2015-02-03
4-amino-4-oxobutanoyl Peptides As Inhibitors Of Viral Replication
App 20140328796 - Phadke; Avinash ;   et al.
2014-11-06
Substituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20140323458 - Wiles; Jason Allan ;   et al.
2014-10-30
Deuterated Nucleoside Prodrugs Useful For Treating Hcv
App 20140309164 - Deshpande; Milind ;   et al.
2014-10-16
Highly Active Nucleoside Derivative For The Treatment Of Hcv
App 20140309189 - Deshpande; Milind ;   et al.
2014-10-16
Sovaprevir Tablets
App 20140271855 - Chu; Jennifer Hsing-Chung ;   et al.
2014-09-18
Ach-0142684 Sodium Salt Polymorph, Composition Including The Same, And Method Of Manufacture Thereof
App 20140274914 - Phadke; Avinash ;   et al.
2014-09-18
Sovaprevir Polymorphs And Methods Of Manufacture Thereof
App 20140275163 - Phadke; Avinash
2014-09-18
Novel Processes For Producing Sovaprevir
App 20140275480 - Phadke; Avinash ;   et al.
2014-09-18
Process For Making A 4-amino-4-oxobutanoyl Peptide Cyclic Analogue, An Inhibitor Of Viral Replication, And Intermediates Thereof
App 20140275520 - Phadke; Avinash ;   et al.
2014-09-18
NS5A inhibitors useful for treating HCV
Grant 8,835,456 - Wiles , et al. September 16, 2
2014-09-16
Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
Grant 8,809,313 - Wiles , et al. August 19, 2
2014-08-19
4-amino-4-oxobutanoyl Peptide Cyclic Analogues, Inhibitors Of Viral Replication
App 20140206604 - Phadke; Avinash ;   et al.
2014-07-24
Macrocyclic peptides as inhibitors of viral replication
Grant 8,785,378 - Phadke , et al. July 22, 2
2014-07-22
New 4-amino-4-oxobutanoyl Peptides As Inhibitors Of Viral Replication
App 20140113890 - Phadke; Avinash ;   et al.
2014-04-24
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
Grant 8,614,180 - Phadke , et al. December 24, 2
2013-12-24
2-substituted-thienoquinolones And Related Compounds As Anti-infective Agents
App 20130165471 - Phadke; Avinash ;   et al.
2013-06-27
Cyclic carboxamide compounds and analogues thereof as of hepatitis C virus
Grant 8,445,430 - Zhang , et al. May 21, 2
2013-05-21
Tertiary amine substituted peptides useful as inhibitors of HCV replication
Grant 8,435,984 - Agarwal , et al. May 7, 2
2013-05-07
Subsituted Aliphanes, Cyclophanes, Heteraphanes, Heterophanes, Hetero-heteraphanes And Metallocenes Useful For Treating Hcv Infections
App 20120302538 - Wiles; Jason Allan ;   et al.
2012-11-29
Heteroaryl substituted thiazoles
Grant 8,183,263 - Wang , et al. May 22, 2
2012-05-22
New Isothiazoloquinolones And Related Compounds As Anti-infective Agents
App 20120114601 - Bradbury; Barton James ;   et al.
2012-05-10
Hydroxylthienoquinolones and related compounds as anti-infective agents
Grant 8,173,636 - Bradbury , et al. May 8, 2
2012-05-08
Thiazole Compounds And Methods Of Use
App 20120108576 - Zhang; Suoming ;   et al.
2012-05-03
Urea-containing peptides as inhibitors of viral replication
Grant 8,163,693 - Chen , et al. April 24, 2
2012-04-24
Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones
Grant 8,138,346 - Bradbury , et al. March 20, 2
2012-03-20
8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones And Related Compounds As Anti-infective Agents
App 20120040959 - Bradbury; Barton James ;   et al.
2012-02-16
Isothiazoloquinolones and related compounds as anti-infective agents
Grant 8,114,888 - Bradbury , et al. February 14, 2
2012-02-14
Substituted aminothiazole prodrugs of compounds with anti-HCV activity
Grant 8,106,209 - Liu , et al. January 31, 2
2012-01-31
Thiazole compounds and methods of use
Grant 8,088,806 - Zhang , et al. January 3, 2
2012-01-03
8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
Grant 8,044,204 - Bradbury , et al. October 25, 2
2011-10-25
Isothiazoloquinolones And Related Compounds As Anti-infective Agents
App 20110223132 - Bradbury; Barton James ;   et al.
2011-09-15
Method For Synthesis Of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
App 20110213152 - Bradbury; Barton James ;   et al.
2011-09-01
Quantitative assay for detection of newly synthesized RNA in a cell-free system and identification of RNA synthesis inhibitors
Grant 7,985,541 - Huang , et al. July 26, 2
2011-07-26
Elvucitabine Pharmaceutical Compositions
App 20110150997 - Shah; Gautam ;   et al.
2011-06-23
Macrocyclic Peptides As Inhibitors Of Viral Replication
App 20110070168 - Phadke; Avinash ;   et al.
2011-03-24
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
Grant 7,906,619 - Phadke , et al. March 15, 2
2011-03-15
Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones
Grant 7,902,365 - Bradbury , et al. March 8, 2
2011-03-08
Tertiary Amine Substituted Peptides Useful As Inhibitors Of Hcv Replication
App 20100292219 - Agarwal; Atul ;   et al.
2010-11-18
Low Dose Therapy For Treating Viral Infections
App 20100256088 - POTTAGE; John
2010-10-07
Hydroxythienoquinolones And Related Compounds As Anti-infective Agents
App 20100256112 - BRADBURY; Barton James ;   et al.
2010-10-07
4-amino-4-oxobutanoyl Peptides As Inhibitors Of Viral Replication
App 20100216725 - Phadke; Avinash ;   et al.
2010-08-26
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
Grant 7,767,706 - Phadke , et al. August 3, 2
2010-08-03
Low dose therapy for treating viral infections
Grant 7,741,334 - Pottage June 22, 2
2010-06-22
4-amino-4-oxobutanoyl Peptide Cyclic Analogues, Inhibitors Of Viral Replication
App 20100152103 - Phadke; Avinash ;   et al.
2010-06-17
Cyclic Carboxamide Compounds And Analogues Thereof As Of Hepatitis C Virus
App 20100124545 - Zhang; Suoming ;   et al.
2010-05-20
Substituted arylthiourea derivatives useful as inhibitors of viral replication
Grant 7,718,671 - Phadke , et al. May 18, 2
2010-05-18
Cells Expressing Chimeric Proteins And Assays Using Such Cells
App 20100093018 - Hou; Xiaohong ;   et al.
2010-04-15
1-thia-2,4a-diaza-cyclopenta[b]napththalene-3,4-diones and related compounds as anti-infective agents
Grant 7,659,399 - Bradbury , et al. February 9, 2
2010-02-09
Combination Therapy For Treating Hepatitis C Infections
App 20100029652 - Huang; Mingjun ;   et al.
2010-02-04
Substituted Aminothiazole Prodrugs of Compounds with Anti-HCV Activity
App 20090304605 - Liu; Cuixan ;   et al.
2009-12-10
Urea-containing Peptides As Inhibitors Of Viral Replication
App 20090082261 - Chen; Dawei ;   et al.
2009-03-26
Heteroaryl Substituted Thiazoles
App 20090041720 - Wang; Xiangzhu ;   et al.
2009-02-12
Substituted aryl thioureas and related compounds; inhibitors of viral replication
Grant 7,476,686 - Chen , et al. January 13, 2
2009-01-13
4-substituted-1h-isothiazolo[5,4-b][1,4]oxazino[2,3,4-ij]quinoline-7,8(2h,- 9h)-diones And Related Compounds As Anti-infective Agents
App 20090012071 - Bradbury; Barton James ;   et al.
2009-01-08
Azabenzofuran substituted thioureas; inhibitors of viral replication
Grant 7,439,374 - Thurkauf , et al. October 21, 2
2008-10-21
Pharmaceutical Compositions For and Methods of Inhibiting Hcv
App 20080207760 - Huang; Mingjun
2008-08-28
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
Grant 7,365,068 - Phadke , et al. April 29, 2
2008-04-29
Method For Synthesis Of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
App 20080071086 - Bradbury; Barton James ;   et al.
2008-03-20
Substituted Aminothiazole Derivatives With Anti-HCV Activity
App 20070213301 - Zhang; Souming ;   et al.
2007-09-13
Substituted Taraxastanes Useful For Treating Viral Infections
App 20070197646 - BRADBURY; Barton James ;   et al.
2007-08-23
8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
Grant 7,199,128 - Bradbury , et al. April 3, 2
2007-04-03
Substituted aryl thioureas and related compounds; inhibitors of viral replication
Grant 7,094,807 - Chen , et al. August 22, 2
2006-08-22
Method for synthesizing .beta.-L-5-fluoro-2',3'-dideoxy-2',3'-didehydrocytidine (.beta.-L-FD4C)
Grant 6,897,302 - Kowalczyk , et al. May 24, 2
2005-05-24
Method for synthesizing beta-L-5-fluoro-2',3'-dideoxy-2',3'-didehydrocytid- ine (beta-L-FD4C)
App 20040147479 - Kowalczyk, Bo ;   et al.
2004-07-29
Antifungal compositions
App 20040018983 - Rice, William G. ;   et al.
2004-01-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed